Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verastem (VSTM) Enterprise Value: 2018-2025

Historic Enterprise Value for Verastem (VSTM) over the last 8 years, with Sep 2025 value amounting to $405.7 million.

  • Verastem's Enterprise Value rose 5571.65% to $405.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.0 million, marking a year-over-year increase of 109.95%. This contributed to the annual value of $141.3 million for FY2024, which is 31.31% down from last year.
  • As of Q3 2025, Verastem's Enterprise Value stood at $405.7 million, which was up 536.78% from $63.7 million recorded in Q2 2025.
  • In the past 5 years, Verastem's Enterprise Value ranged from a high of $591.6 million in Q2 2021 and a low of -$58.6 million during Q2 2023.
  • In the last 3 years, Verastem's Enterprise Value had a median value of $51.7 million in 2023 and averaged $94.4 million.
  • As far as peak fluctuations go, Verastem's Enterprise Value plummeted by 148.04% in 2023, and later skyrocketed by 5,571.65% in 2025.
  • Verastem's Enterprise Value (Quarterly) stood at $219.7 million in 2021, then tumbled by 103.40% to -$7.5 million in 2022, then fell by 28.81% to $39.6 million in 2023, then plummeted by 81.95% to $141.3 million in 2024, then skyrocketed by 5,571.65% to $405.7 million in 2025.
  • Its Enterprise Value was $405.7 million in Q3 2025, compared to $63.7 million in Q2 2025 and $192.9 million in Q1 2025.